TrialJournal of acquired immune deficiency syndromes (1999)2011

Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin.

Andrew H Talal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.